Apyx Medical Corp 8-K

What Happened

• Apyx Medical Corporation announced its results of operations for the quarter ended March 31, 2026 by issuing a press release dated May 7, 2026. The company furnished that press release as Exhibit 99.1 to an 8-K filed on May 7, 2026 under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Date of press release: May 7, 2026.
• Reporting period: Quarter ended March 31, 2026.
• Filing: Form 8‑K furnished under Item 2.02; Exhibit 99.1 (earnings press release) and Exhibit 104 (Inline XBRL cover page) attached.
• The 8‑K furnishes the press release; it does not itself restate the full financial figures in the filing text (see Exhibit 99.1 for details).

Why It Matters

• This filing signals that Apyx has released its quarterly earnings and related financial information. Retail investors should read the attached press release (Exhibit 99.1) for specific metrics—revenue, net income (or loss), cash position, and any commentary on guidance or business trends—to assess the company’s recent performance.
• Because the 8‑K furnishes the press release, investors should rely on the exhibit for concrete numbers and any management commentary that may affect valuation, trading decisions, or follow-up filings.